# Abeona Therapeutics (ABEO) — Analyst Forecast

ABEO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/abeo/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 7 | 0 | 0 | 7 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $17.00 | $22.67 | $30.00 | 3 |

Last price $4.65 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 18, 2026 | Cantor Fitzgerald | Maintained | Overweight | $30.00 |
| Sep 17, 2026 | Roth Capital | Initiated Coverage | Buy | $17.00 |
| Aug 14, 2026 | Oppenheimer | Maintained | Outperform | $21.00 |
| May 28, 2026 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Mar 19, 2026 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Mar 10, 2026 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Oct 13, 2025 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Aug 18, 2025 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Aug 15, 2025 | Oppenheimer | Maintained | Outperform | $20.00 |
| Jul 16, 2025 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Jul 14, 2025 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Jun 2, 2025 | Oppenheimer | Initiated Coverage | Outperform | $19.00 |
| May 16, 2025 | Stifel | Maintained | Buy | $20.00 |
| Apr 30, 2025 | HC Wainwright & Co. | Maintained | Buy | $20.00 |
| Mar 24, 2025 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| Mar 5, 2025 | Oppenheimer | Initiated Coverage | Outperform | $16.00 |
| Feb 19, 2025 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| Nov 25, 2024 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| Oct 31, 2024 | HC Wainwright & Co. | Maintained | Buy | $15.00 |
| Oct 29, 2024 | Cantor Fitzgerald | Maintained | Overweight | $18.00 |

## Frequently Asked Questions

### What is the price target for ABEO stock?

The average 12-month analyst price target for Abeona Therapeutics (ABEO) is $22.67, with a high estimate of $30.00 and a low of $17.00, across 3 analysts.

### Is ABEO a buy, sell, or hold?

Analysts covering Abeona Therapeutics currently average a Buy rating: 7 buy, 0 hold and 0 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for ABEO?

The average price target of $22.67 implies 387.46% upside from the last price of $4.65.

### What is the latest analyst rating on ABEO?

On Sep 18, 2026, Cantor Fitzgerald maintained Abeona Therapeutics at Overweight with a price target of $30.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).